Natural killer T (NKT) cells, a type of immune cells
Noninvasive technique to assess brain tumors in children and make treatment less toxic
Ground-breaking research by the University of Birmingham has discovered a
Mom covered in thousands of tumors due to rare genetic disorder: 'It's really rough and depressing'
Fox News Flash top headlines for Jan. 2 Fox News
Promising system delivers chemo drug straight into tumors with fewer side effects
A stealthy new drug-delivery system disguises chemotherapeutics as fat in
Discovery of ‘kingpin’ stem cell may help in the understanding of cancerous tumors
A team of McMaster University researchers has discovered a unique
CD40 combination therapy can shrink pancreatic tumors
A new combination of immunotherapy and chemotherapy for pancreatic cancer
$9 million supports deep dive into breast, pancreatic cancers
Washington University School of Medicine in St. Louis has received
Radiation of mobile phones affect the development of cancer, scientists say
American biologists have stated about new potential evidence that radio
Supplements with antioxidants can accelerate the growth of malignant tumors
There’s new evidence of a link between bioactive additives with
Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 23, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a